Concepedia

Anne Aarnink

AA

Statistics

Publications

4

Citations

148

H-Index

4

Active since

2017

Affiliations

Centre Georges François Leclerc(Current)

Genomic and Immunotherapy Medical Institute

Inserm

Université Bourgogne Franche-Comté

CHU Dijon Bourgogne

Anne Aarnink is an author at Centre Georges François Leclerc specializing in oncology, non-small cell lung cancer immunotherapy, and pharmacology.

Publications per year

2017–2020

4

Publications

4

Antibiotic Use Does Not Appear to Influence Response to Nivolumab

Courèche Kaderbhaï, Corentin Richard, Jean David Fumet et al. · Anticancer Research · 2017 · 108 citations · Full text

, , +12

Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France

Anne Aarnink, Jean David Fumet, Laure Favier et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 16 citations · Full text

, , +17

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer

Courèche-Guillaume Kaderbhai, Corentin Richard, Jean David Fumet et al. · OncoImmunology · 2017 · 13 citations · Full text

, , +16

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma

Anne Aarnink, Corentin Richard, Caroline Truntzer et al. · Oncotarget · 2018 · 11 citations · Full text

, , +16

1–4 of 4